We explore CAR T-cell therapy challenges, regulatory approvals, market growth, pricing models, and a...
Read moreMEAs resulted in 195.2 million of savings for the Italian healthcare system, according to AIFA’s M...
Read moreProject to help the EU develop new pricing and payment models to fund high-priced drugs and relieve ...
Read moreNICE have recommended Enhertu for the treatment of HER2-positive breast cancer within a managed acce...
Read moreOur client wanted to develop a training programme to help their employees learn about the value of M...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreWe analyse subscription-based agreements for antibiotics in Europe to understand how it may address ...
Read moreThe report looks at how differences in cancer survival rates between the UK and other countries have...
Read moreAccording to the Institute for Quality and Efficiency in Health Care orphan drugs should undergo ear...
Read moreThe highly specialised technologies (HST) process was introduced in 2013 for the purpose of evaluati...
Read more